Related Experiment Videos
Studies on the anti-inflammatory action of 6-mercaptopurine
Abstract:
The mechanism of action of 6-mercaptopurine (6-MP) on an egg albumin-induced inflammatory lesion in the skin has been studied in rabbits treated with 6-MP in a daily dosage of 18 mg/kg. Relative to control animals, significant decreases in the numbers of large lymphocytes and monocytes in the blood were observed in the 6-MP-treated animals by the 9th day of treatment, without significant decrease in the numbers of polymorphonuclear leukocytes and small and medium lymphocytes. Concurrently, a significant decrease was also seen in the percentage of tissue mononuclear cells in the inflammatory skin lesion. There was a highly significant correlation between the numbers of monocytes in the blood and the per cent of mononuclear cells in the lesion. A mean of 52% of the mononuclear cells in the tissue lesion phagocytosed carbon offering further evidence that the major cell involved was the blood monocyte. In vitro incorporation of (3)H-Tdr by blood mononuclear cells was significantly reduced in the 6-MP-treated animals as determined by scintillation counting and radioautography. The large lymphocyte was the predominant cell type which was labeled in vitro. Small lymphocytes and monocytes were rarely labeled. The data obtained suggest that the anti-inflammatory effect of 6-MP, reflected in these experiments by a decrease in mononuclear cells in a tissue lesion, results from suppression of a bone marrow response to local inflammation, affecting principally proliferating precursors of blood monocytes and large lymphocytes. The possible importance of this action of 6-MP in the treatment of inflammatory and immunologically mediated disease is discussed.
Insights
6-mercaptopurine (6-MP) reduces inflammation by decreasing blood monocytes and large lymphocytes, key cells in inflammatory lesions. This suggests 6-MP may suppress bone marrow responses to inflammation.
Area of Science:
- Immunology
- Pharmacology
- Dermatology
Background:
- Inflammatory skin lesions involve complex cellular responses.
- 6-mercaptopurine (6-MP) is an immunosuppressive drug with known anti-inflammatory effects.
Purpose of the Study:
- To elucidate the mechanism of action of 6-mercaptopurine (6-MP) in an experimental inflammatory skin lesion model.
- To investigate the effects of 6-MP on specific immune cell populations in blood and affected tissue.
Main Methods:
- Rabbits with egg albumin-induced skin lesions were treated daily with 6-MP (18 mg/kg).
- Blood cell counts, including lymphocytes and monocytes, were monitored.
- Cellular infiltration and phagocytic activity within skin lesions were assessed.
- In vitro incorporation of (3H-Tdr) by blood mononuclear cells was measured using scintillation counting and radioautography.
Main Results:
- 6-MP treatment significantly decreased blood monocytes and large lymphocytes by day 9.
- A significant reduction in mononuclear cells within the inflammatory skin lesion was observed.
- Mononuclear cells in the lesion demonstrated phagocytic activity, indicating monocyte involvement.
- In vitro proliferation of blood mononuclear cells, particularly large lymphocytes, was significantly reduced by 6-MP.
Conclusions:
- 6-MP exerts anti-inflammatory effects by suppressing bone marrow precursors of monocytes and large lymphocytes.
- The reduction in these cell types in circulation and tissue lesions contributes to 6-MP's therapeutic action.
- These findings highlight the potential of 6-MP in treating inflammatory and immune-mediated diseases.